Kaken Pharmaceutical (4521.TSE) Q1 2025 Earnings

6FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
42.24
145.28
248.32
351.37

Details

Expected EPS
N/A
Actual EPS
124.13648899680001
Surprise EPS
124.14
Surprise Percent
+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 124.13648899680001 per share for Q1 2025.

0 Comments

Share your thoughts